Triglyceride breakdown from lipid droplets regulates the inflammatory response in macrophages
In response to inflammatory activation by pathogens, macrophages accumulate triglycerides in intracellular lipid droplets. The mechanisms underlying triglyceride accumulation and its exact role in the inflammatory response of macrophages are not fully understood. Here, we aim to further elucidate th...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 119; no. 12; p. e2114739119 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
22.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In response to inflammatory activation by pathogens, macrophages accumulate triglycerides in intracellular lipid droplets. The mechanisms underlying triglyceride accumulation and its exact role in the inflammatory response of macrophages are not fully understood. Here, we aim to further elucidate the mechanism and function of triglyceride accumulation in the inflammatory response of activated macrophages. Lipopolysaccharide (LPS)-mediated activation markedly increased triglyceride accumulation in macrophages. This increase could be attributed to up-regulation of the hypoxia-inducible lipid droplet–associated (HILPDA) protein, which down-regulated adipose triglyceride lipase (ATGL) protein levels, in turn leading to decreased ATGL-mediated triglyceride hydrolysis. The reduction in ATGL-mediated lipolysis attenuated the inflammatory response in macrophages after ex vivo and in vitro activation, and was accompanied by decreased production of prostaglandin-E2 (PGE2) and interleukin-6 (IL-6). Overall, we provide evidence that LPS-mediated activation of macrophages suppresses lipolysis via induction of HILPDA, thereby reducing the availability of proinflammatory lipid precursors and suppressing the production of PGE2 and IL-6. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by Katherine Fitzgerald, University of Massachusetts Medical School, Worcester, MA; received August 13, 2021; accepted January 26, 2022 Author contributions: X.A.M.H.v.D., S.K., and R.S. designed research; X.A.M.H.v.D., F.V., L.S., L.D., J.P.B., and C.-A.C. performed research; L.T., S.W., and E.B. contributed new reagents/analytic tools; X.A.M.H.v.D. and F.V. analyzed data; and X.A.M.H.v.D., S.K., and R.S. wrote the paper. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.2114739119 |